Letter to the Editor : Antimicrobial Photodynamic Therapy with Hypocrellin B against SARS-CoV-2 infection?

Siukan LAW, Chuiman LO, Jie HAN, Wing Nang Albert LEUNG, Chuanshan XU*

*Corresponding author for this work

Research output: Other PublicationsOther ArticleCommunication

Abstract

Dear Editor,
We still do not have effective therapy to combat SARS-CoV-2 except vaccination. Antimicrobial photodynamic therapy (aPDT) might be a good choice for the prevention and treatment of SARS-CoV-2 because it may only target the infection area using photosensitizers with a specific wavelength. “Hypocrellin B” is a substance used traditionally in Chinese medicine and as a photosensitizer which is used in China to treat many diseases. Its photodynamic action and research progress of "hypocrellin B" will be discussed. Why do we apply PDT with "hypocrellin B" as a photosensitizer against SARS-CoV-2? Is this a possible choice for the treatment of patients with SARS-CoV-2?
Original languageEnglish
Volume34
Specialist publicationPhotodiagnosis and Photodynamic Therapy
DOIs
Publication statusE-pub ahead of print - 20 Apr 2021

Fingerprint Dive into the research topics of 'Letter to the Editor : Antimicrobial Photodynamic Therapy with Hypocrellin B against SARS-CoV-2 infection?'. Together they form a unique fingerprint.

Cite this